Edition:
United States

Sientra Inc (SIEN.OQ)

SIEN.OQ on NASDAQ Stock Exchange Global Select Market

15.26USD
15 Dec 2017
Change (% chg)

$0.38 (+2.55%)
Prev Close
$14.88
Open
$14.91
Day's High
$15.45
Day's Low
$14.81
Volume
50,701
Avg. Vol
44,604
52-wk High
$16.61
52-wk Low
$7.21

Latest Key Developments (Source: Significant Developments)

Sientra posts qtrly loss of $0.74​ per share
Tuesday, 7 Nov 2017 04:01pm EST 

Nov 7 (Reuters) - Sientra Inc :Sientra reports third quarter 2017 financial results.Total net sales for Q3 2017 were $9.8 million, compared to total net sales of $6.5 million for same period in 2016​.Qtrly ‍basic and diluted net loss per share attributable to common stockholders $0.74​.Net cash and cash equivalents as of September 30, 2017 were $37.6 million compared to $55.5 million at end of Q2 2017​.  Full Article

Sientra reports Q2 net loss per share attributable to stockholders $1.07​
Wednesday, 9 Aug 2017 04:01pm EDT 

Aug 10 (Reuters) - Sientra Inc -:Sientra® reports second quarter 2017 financial results.Q2 sales $8.2 million versus I/B/E/S view $7 million.Sientra Inc qtrly ‍basic and diluted net loss per share attributable to common stockholders $1.07​.  Full Article

Sientra, Silimed reach settlement of lawsuit and related arbitration
Tuesday, 1 Aug 2017 09:16am EDT 

Aug 1 (Reuters) - Sientra Inc ::Sientra says on June 27, co, Silimed Ind*A De Implantes Ltda reached settlement of lawsuit and related arbitration between them - SEC filing.Sientra says co agreed to pay Silimed lump sum of $9 million within 30-days of execution of settlement agreement, $1 million on or by July 1, 2018-SEC filing.Sientra Inc - company and Silimed have granted each other covenants not to sue with respect to certain specified conduct.Sientra Inc - parties executed settlement agreement on July 27, 2017.Sientra - should co enter international markets, has agreed to make royalty payments of $12.50 on net sales of certain breast implant specifications, up to $5 million.  Full Article

Sientra says settles lawsuit
Tuesday, 1 Aug 2017 08:30am EDT 

Aug 1 (Reuters) - Sientra Inc :Sientra announces settlement of lawsuit.Sientra - has entered into settlement agreement regarding mutual ip ownership and contract disputes with Silimed-Indústria De Implantes Ltda.  Full Article

Sientra Inc says amendment permits merger to be effected as a "short-form" merger‍​
Monday, 26 Jun 2017 06:25am EDT 

June 26 (Reuters) - Sientra Inc :Sientra Inc - co, Desert Acquisition Corp and Miramar Labs Inc. Entered into amendment no. 1 to agreement and plan of merger.Sientra Inc - the amendment permits the merger to be effected as a “short-form” merger‍​.Sientra Inc - amendment grants to co's unit right to buy from Miramar newly issued shares at a price equal to offer price- sec filing.  Full Article

Sientra to acquire Miramar labs for $20 million​
Monday, 12 Jun 2017 08:00am EDT 

June 12 (Reuters) - Sientra Inc :Sientra to acquire Miramar labs.‍sientra intends to secure a $50 million credit facility​.Keith Sullivan joins Sientra as strategic advisor.Sientra has agreed to acquire Miramar for an aggregate transaction value of $20 million​.Deal includes contractual rights for potential contingent payments of up to $14 million in cash upon achievement of certain milestones.Expect transaction to be meaningfully accretive to full year 2018 revenues.Transaction is not subject to a financing condition.Co has sufficient cash on hand to finance transaction.Co has also signed a term sheet with midcap financial services and silicon valley bank for a $50 million credit facility.Deal contemplates offer price of $0.3149/share plus right to get 1 or more contingent payments of up to about $0.7058/share on certain milestones ​.Subject to execution of definitive agreements, credit facility to be comprised of $40 million in term debt and a $10 million revolver.New credit facility is intended to replace Sientra's existing $20 million credit facility announced in march of 2017.  Full Article

Sientra reports Q1 loss per share of $0.61
Tuesday, 9 May 2017 04:01pm EDT 

May 9 (Reuters) - Sientra Inc :Sientra® reports first quarter 2017 financial results.Q1 sales $7.5 million versus $1.5 million.Q1 revenue view $6 million -- Thomson Reuters I/B/E/S.Sientra Inc qtrly loss per share $0.61.Q1 earnings per share view $-0.49, revenue view $6.0 million -- Thomson Reuters I/B/E/S.  Full Article

Sientra Q4 sales $6.5 million versus $1.5 million
Tuesday, 14 Mar 2017 04:01pm EDT 

Sientra Inc : Sientra reports fourth quarter and full year 2016 financial results . Q4 sales $6.5 million versus $1.5 million . Sientra inc- net loss for q4 of 2016 was $8.1 million, compared to $28.3 million for same period in 2015 . Sientra inc - announces $15 million line of credit with an additional $5 million credit facility . Sientra inc- net cash and cash equivalents were $67.2 million as of december 31, 2016 . Sientra inc - submitted final pma supplement to fda for new u.s. Manufacturing site .Sientra inc - "2017 is a pivotal year for us as we prepare to move into 2018 and beyond with our breast implant supply chain back and intact".  Full Article

Sientra receives FDA approval of new silicone breast implant styles and sizes
Monday, 5 Dec 2016 04:01pm EST 

Sientra Inc : Sientra® receives FDA approval of new silicone breast implant styles and sizes .Expect to deliver newly manufactured product to market by end of Q4 of 2017.  Full Article

Sientra acquires tissue expander portfolio from specialty surgical products
Tuesday, 8 Nov 2016 04:01pm EST 

Sientra Inc : Sientra® Acquires tissue expander portfolio from specialty Surgical Products, Inc. .Sientra® acquires tissue expander portfolio from specialty Surgical Products, Inc..  Full Article

BRIEF-Sientra posts qtrly loss of $0.74​ per share

* Total net sales for Q3 2017 were $9.8 million, compared to total net sales of $6.5 million for same period in 2016​